Aandeel DNA GINO BIOW
Toevoegen aan een lijst
Om deze functie te gebruiken moet u een klant of lid zijn.
InloggenRegistreren
Inactief instrument

Andere talen GINO BIOW Nasdaq

Aandelen

DNA

US37611X1000

Andere talen

Zoeken op
Resultaten bekijken
Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!
Gratis inschrijven
Global Retail Giant Enhances Warehouse Efficiency with Vuzix (VUZI) Smart Glasses Rollout
Il Granaio delle Idee and Ginkgo Bioworks Announce Strategic Collaboration to Optimize Sourdough Strains for Bakery Products
Il Granaio delle Idee and Ginkgo Bioworks Announces Strategic Collaboration to Optimize Sourdough Strains for Bakery Products
Modalis Announces Partnership with Ginkgo Bioworks
Ginkgo Bioworks Previews Today's Annual Ferment Conference, Announces 'Lab Data as a Service'
Ginkgo Bioworks Acquires AgBiome's Platform Assets
Ginkgo Bioworks Announces Acquisition of AgBiome's Platform Assets
Ginkgo Bioworks Previews Today's Annual Ferment Conference, Announces "Lab Data as a Service"
Ginkgo Bioworks Expands Research Partnership With Novo Nordisk
Ginkgo Bioworks and Novo Nordisk Expand Alliance to Collaborate Across R&D Value Chain
Ginkgo Bioworks Awarded Grant for AI-enabled Forecasting of Measles Outbreaks
Ginkgo Bioworks Partners With IdeeLab Biotechnology in Brazil
IdeeLab Joins the Ginkgo Technology Network to Provide Agriculture Companies in Brazil with End-to-End Product Development & Manufacturing Service
IdeeLab Joins the Ginkgo Technology Network to Provide Agriculture Companies in Brazil with End-to-End Product Development & Manufacturing Service
Ginkgo Bioworks to Host 5th Annual Ferment Conference
Ginkgo Bioworks, Prozomix Collaborate on Enzyme Development
Ginkgo Bioworks Acquires Modulus Therapeutics Cell Therapy Assets to Strengthen Next-Gen CAR Designs
Prozomix and Ginkgo Bioworks Collaborate on Next-Gen Enzyme Development for Sustainable API Manufacturing
Prozomix and Ginkgo Bioworks Collaborate on Next-Gen Enzyme Development for Sustainable API Manufacturing
Ginkgo Bioworks (NYSE: DNA) completed the acquisition of cell therapy platform assets of Modulus Therapeutics.
Geen resultaten voor deze zoekopdracht
Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Filters

Zoeken op

Datum van publicatie

Sinds de

Tot

  1. Beurs
  2. Aandelen
  3. Koers DNA
  4. Koers DNA
  5. Nieuws GINO BIOW
  6. Andere talen